Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study

BACKGROUND: Liquid biopsy approaches, such as measuring circulating tumour cells (CTCs), have recently been introduced in several clinical studies. However, the development of CTCs as a predictive marker for treatment effects on breast cancer remains an enormous task. We investigated CTCs, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Horimoto, Yoshiya, Tokuda, Emi, Murakami, Fumi, Uomori, Toshitaka, Himuro, Takanori, Nakai, Katsuya, Orihata, Gotaro, Iijima, Kotaro, Togo, Shinsaku, Shimizu, Hideo, Saito, Mitsue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195982/
https://www.ncbi.nlm.nih.gov/pubmed/30342534
http://dx.doi.org/10.1186/s12967-018-1663-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195982/
https://www.ncbi.nlm.nih.gov/pubmed/30342534
http://dx.doi.org/10.1186/s12967-018-1663-8

Ejemplares similares